Your browser doesn't support javascript.
loading
Levamisole suppresses activation and proliferation of human T cells by the induction of a p53-dependent DNA damage response.
Khan, Gerarda H; Veltkamp, Floor; Scheper, Mirte; Hoebe, Ron A; Claessen, Nike; Butter, Loes; Bouts, Antonia H M; Florquin, Sandrine; Guikema, Jeroen E J.
Affiliation
  • Khan GH; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Veltkamp F; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Scheper M; Department of Pediatric Nephrology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Hoebe RA; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Claessen N; Department of Medical Biology, Amsterdam UMC and Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Butter L; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Bouts AHM; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Florquin S; Department of Pediatric Nephrology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Guikema JEJ; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Eur J Immunol ; 53(11): e2350562, 2023 11.
Article in En | MEDLINE | ID: mdl-37597325

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Levamisole / Tumor Suppressor Protein p53 Limits: Humans Language: En Journal: Eur J Immunol Year: 2023 Document type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Levamisole / Tumor Suppressor Protein p53 Limits: Humans Language: En Journal: Eur J Immunol Year: 2023 Document type: Article Affiliation country: Netherlands